First Week of MGNI September 18th Options Trading

Magnite (MGNI) is presented as a candidate for income-oriented option strategies at a spot price of $14.91. Selling the $13.00 put (bid $1.85) would set an effective cost basis of $11.15 and is estimated to have a 71% chance to expire worthless, producing a 14.23% return (21.20% annualized) if so. Conversely, writing the $16.00 covered call (bid $2.50) against shares bought at $14.91 would cap upside at $16.00 but yield a 24.08% total return if called away and has a 42% probability of expiring worthless (16.77% yield boost, 24.98% annualized). Implied volatilities are ~71–72% vs. a trailing 12‑month realized volatility of 64%.

Analysis

Market structure: The immediate beneficiaries are option premium sellers and cash-rich investors willing to take equity exposure in MGNI at a lower effective cost (sell $13 put, collect $1.85 -> $11.15 basis). High implied vol (71–72%) versus realized vol (64%) signals a 7–8ppt IV premium; that favors systematic option sellers and increases dealers’ hedging flows, compressing liquidity on large intraday moves. Cross-asset impact is limited but a volatility pick-up in ad-tech could bid hedges (VIX/treasuries) modestly and increase short-term repo/financing demands for levered players.

Risk assessment: Tail risks include a sharp ad demand shock (budget cuts >10% QoQ), privacy/regulatory action that reduces programmatic yield, or a liquidity squeeze that widens spreads—any could turn a profitable put seller into a large drawdown. Time horizons matter: theta dominates over days–weeks (put/call decay to Sep 18), earnings/guide updates drive medium-term (1–3 months), and structural ad-revenue trends determine long-term (4+ quarters). Hidden risks: assignment concentration, borrow/transaction costs, and IV re-rating that can make covered-call upside opportunity cost steep.

Trade implications: Tactical trades that match risk appetite: for cash-secured exposure sell-to-open 1x MGNI $13 Sep18 put (collect $1.85) sized to 1–3% NAV; if unwilling to accept naked downside, do a $12/$13 put credit spread to cap max loss (~$0.85). For existing longs, sell the $16 Sep18 call for $2.50 to harvest ~24% capped return; if you expect a rebound, prefer buying a Jan24 call or 2x long-month call spread instead of selling upside. Relative idea: go long MGNI equity + short a high-multiple ad-tech peer or fund to isolate company-specific outperformance.

Contrarian view: The market may be underestimating fundamentals improvements (ad pricing inflection) or overpricing idiosyncratic risk via IV; given IV>realized, option-selling is likely to be edge but not free—histor precedents show sharp IV jumps erase premium quickly. The consensus yield-boost narrative ignores assignment sequencing risk and potential for multi-quarter ad softness; size positions assuming a 20–30% drawdown tail and use spreads or staggered expiries to manage that risk.

Key Decisions for Investors

• Sell-to-open MGNI Sep18 $13 cash-secured puts (collect $1.85) sized to 1–3% of fund NAV to target an effective basis of $11.15; plan to hold through expiry or take assignment if MGNI <= $13, and cap position by buying a $11 protective put if assigned.
• If already long MGNI at ~$14.91, sell Sep18 $16 covered calls (collect $2.50) to lock a capped gross return ~24% to Sep18; size to no more than 50% of intended long exposure to preserve upside optionality.
• If uncomfortable with naked exposure, implement a bearish-limited risk alternative: buy MGNI Sep18 $13/$11 put spread (pay ~ $X, expect <$0.85) or sell $13/$12 put credit spread to limit downside to ~$0.85 per share on a 1–2% NAV allocation.
• Establish a pair trade: long MGNI (2% NAV) funded by shorting a high-multiple ad-tech peer or small-cap ad-tech ETF (2% NAV) to isolate company-specific recovery; exit or rebalance on a +15% relative move or after next quarterly revenue print.
• Monitor four near-term catalysts over next 30–60 days before scaling: (1) MGNI quarterly rev/guidance, (2) programmatic CPM trends (seek >5% QoQ improvement), (3) industry privacy/regulatory announcements, and (4) IV vs realized spread—if IV compresses below realized by >3ppt, reduce option-selling exposure.